237736-13-9

Upstream product

• 182268-43-5 Ethyl threo-3-(p-methoxyphenyl)-2(R),3(S)-dihydroxypropionate 
• 237736-21-9 (1S,2S)-1-(4-Methoxy-phenyl)-propane-1,2,3-triol 
• 24393-56-4 ethyl (E)-3-(4-methoxyphenyl)prop-2-enoate 
• 237736-12-8 (1S,2S)-3-(tert-Butyl-diphenyl-silanyloxy)-1-(4-methoxy-phenyl)-propane-1,2-diol 

Downstream Products

• 237736-22-0 (2R,3R)-3-Azido-3-(4-methoxy-phenyl)-propane-1,2-diol 
• 237736-14-0 (1R,2R)-1-Azido-3-(tert-butyl-diphenyl-silanyloxy)-1-(4-methoxy-phenyl)-propan-2-ol 
• 220736-25-4 (4R,5R)-cytoxazone 
• 237736-16-2 (4R,5R)-5-(tert-butyldiphenylsilyloxymethyl)-4-(4-methoxyphenyl)oxazolidin-2-one 
• 237736-23-1 Carbonic acid (1R,2R)-2-azido-1-(tert-butyl-diphenyl-silanyloxymethyl)-2-(4-methoxy-phenyl)-ethyl ester phenyl ester 

Relevant academic research and scientific papers

Stereoselective syntheses of cytoxazone, a novel cytokine modulator, and its stereoisomers

Cytoxazone, a novel cytokine modulator, and its stereoisomers were stereoselectively synthesized via stereocontrolled introduction of an azide group and direct construction of the 2-oxazolidinone ring from an azide carbonate by reductive cyclization.